...
search icon
trib-img

Trinity Biotech plc Share Price

TRIB
NSQ
$0.905
+$0.11
(13.9%)
1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Trinity Biotech plc Analyst Forecast

Trinity Biotech plc Share Price Chart

Trinity Biotech plc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$14.81M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
668.41K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.50
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.48 L
$1.97 H
$0.905

About Trinity Biotech plc, Common Stock

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. In addition, the company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. It serves public health authorities, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc It has a collaboration agreement with a bioinformatics company to conduct analysis on clinical trial data for EpiCapture, a PCR-based epigenetic liquid biopsy test for monitoring the risk of prostate cancer progressing to aggressive forms of the disease. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Trinity Biotech plc Stock Returns

Time FrameTRIBSectorS&P500
1-Week Return31.16%1.64%-0.4%
1-Month Return-29.3%2.13%0.14%
3-Month Return-4.74%8.39%2.61%
6-Month Return23.96%16.16%8.7%
1-Year Return17.38%9.86%13%
3-Year Return-83.55%17.8%72.1%
5-Year Return-96.11%33.74%79.31%
10-Year Return-98.29%135.48%268.2%

Trinity Biotech plc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue101.98M81.15M62.52M56.83M61.55M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":79.57,"profit":true},{"date":"2022-12-31","value":61.31,"profit":true},{"date":"2023-12-31","value":55.73,"profit":true},{"date":"2024-12-31","value":60.36,"profit":true}]
Cost of Revenue53.40M54.89M52.73M37.38M40.11M[{"date":"2020-12-31","value":97.29,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.07,"profit":true},{"date":"2023-12-31","value":68.11,"profit":true},{"date":"2024-12-31","value":73.08,"profit":true}]
Gross Profit48.58M33.45M22.05M19.45M21.44M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":68.86,"profit":true},{"date":"2022-12-31","value":45.38,"profit":true},{"date":"2023-12-31","value":40.04,"profit":true},{"date":"2024-12-31","value":44.14,"profit":true}]
Gross Margin47.64%41.23%35.26%34.22%34.83%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":86.54,"profit":true},{"date":"2022-12-31","value":74.03,"profit":true},{"date":"2023-12-31","value":71.84,"profit":true},{"date":"2024-12-31","value":73.12,"profit":true}]
Operating Expenses48.50M29.52M32.96M46.49M42.61M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":60.86,"profit":true},{"date":"2022-12-31","value":67.96,"profit":true},{"date":"2023-12-31","value":95.87,"profit":true},{"date":"2024-12-31","value":87.85,"profit":true}]
Operating Income82.00K3.94M(15.27M)(27.05M)(21.16M)[{"date":"2020-12-31","value":2.08,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-387.73,"profit":false},{"date":"2023-12-31","value":-686.77,"profit":false},{"date":"2024-12-31","value":-537.46,"profit":false}]
Total Non-Operating Income/Expense(11.57M)(10.67M)(48.87M)(19.76M)(22.70M)[{"date":"2020-12-31","value":-1157100000,"profit":false},{"date":"2021-12-31","value":-1067000000,"profit":false},{"date":"2022-12-31","value":-4887300000,"profit":false},{"date":"2023-12-31","value":-1976400000,"profit":false},{"date":"2024-12-31","value":-2269700000,"profit":false}]
Pre-Tax Income(6.63M)(1.92M)(43.78M)(36.93M)(30.73M)[{"date":"2020-12-31","value":-663300000,"profit":false},{"date":"2021-12-31","value":-192400000,"profit":false},{"date":"2022-12-31","value":-4378000000,"profit":false},{"date":"2023-12-31","value":-3692700000,"profit":false},{"date":"2024-12-31","value":-3073000000,"profit":false}]
Income Taxes(620.00K)(74.00K)(194.00K)(59.00K)486.00K[{"date":"2020-12-31","value":-127.57,"profit":false},{"date":"2021-12-31","value":-15.23,"profit":false},{"date":"2022-12-31","value":-39.92,"profit":false},{"date":"2023-12-31","value":-12.14,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(6.01M)(1.85M)(43.59M)(36.87M)(31.22M)[{"date":"2020-12-31","value":-601300000,"profit":false},{"date":"2021-12-31","value":-185000000,"profit":false},{"date":"2022-12-31","value":-4358600000,"profit":false},{"date":"2023-12-31","value":-3686800000,"profit":false},{"date":"2024-12-31","value":-3121600000,"profit":false}]
Income From Continuous Operations15.67M9.15M(41.00M)(36.87M)(31.22M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":58.42,"profit":true},{"date":"2022-12-31","value":-261.63,"profit":false},{"date":"2023-12-31","value":-235.25,"profit":false},{"date":"2024-12-31","value":-199.18,"profit":false}]
Income From Discontinued Operations(375.00K)(54.00K)---[{"date":"2020-12-31","value":-37500000,"profit":false},{"date":"2021-12-31","value":-5400000,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(6.39M)875.00K(41.00M)(24.02M)(31.79M)[{"date":"2020-12-31","value":-730.06,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-4685.94,"profit":false},{"date":"2023-12-31","value":-2744.91,"profit":false},{"date":"2024-12-31","value":-3633.03,"profit":false}]
EPS (Diluted)0.700.30(1.03)(0.54)(6.28)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":43.17,"profit":true},{"date":"2022-12-31","value":-147.78,"profit":false},{"date":"2023-12-31","value":-76.76,"profit":false},{"date":"2024-12-31","value":-900.57,"profit":false}]

Trinity Biotech plc Ratios

Trinity Biotech plc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

TRIB
Cash Ratio 0.04
Current Ratio 1.03
Quick Ratio 0.47

Trinity Biotech plc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TRIB
ROA (LTM) -10.53%
ROE (LTM) -1913.45%

Trinity Biotech plc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TRIB
Debt Ratio Lower is generally better. Negative is bad. 1.53
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.53

Trinity Biotech plc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TRIB
Trailing PE NM
Forward PE NM
P/S (TTM) 0.30
P/B 5.11
Price/FCF NM
EV/R 2.51
EV/Ebitda NM
PEG 1.30

FAQs

What is Trinity Biotech plc share price today?

Trinity Biotech plc (TRIB) share price today is $0.905

Can Indians buy Trinity Biotech plc shares?

Yes, Indians can buy shares of Trinity Biotech plc (TRIB) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TRIB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Trinity Biotech plc be purchased?

Yes, you can purchase fractional shares of Trinity Biotech plc (TRIB) via the Vested app. You can start investing in Trinity Biotech plc (TRIB) with a minimum investment of $1.

How to invest in Trinity Biotech plc shares from India?

You can invest in shares of Trinity Biotech plc (TRIB) via Vested in three simple steps:

  • Click on Sign Up or Invest in TRIB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Trinity Biotech plc shares
What is Trinity Biotech plc 52-week high and low stock price?

The 52-week high price of Trinity Biotech plc (TRIB) is $1.97. The 52-week low price of Trinity Biotech plc (TRIB) is $0.48.

What is Trinity Biotech plc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Trinity Biotech plc (TRIB) is

What is Trinity Biotech plc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Trinity Biotech plc (TRIB) is 5.11

What is Trinity Biotech plc dividend yield?

The dividend yield of Trinity Biotech plc (TRIB) is 0.00%

What is the Market Cap of Trinity Biotech plc?

The market capitalization of Trinity Biotech plc (TRIB) is $14.81M

What is Trinity Biotech plc's stock symbol?

The stock symbol (or ticker) of Trinity Biotech plc is TRIB

How Can Investors Use Trinity Biotech plc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Trinity Biotech plc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Trinity Biotech plc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Trinity Biotech plc shares for Indian investors?

When investing in Trinity Biotech plc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Trinity Biotech plc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Trinity Biotech plc share price with other stocks in the same sector?

Rather than merely checking the share price of Trinity Biotech plc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Trinity Biotech plc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top